Furthermore, to increase the therapeutic efficacy, thereby attenuating dose‐dependent toxicity of HDAC inhibitor vorinostat, a phosphodiesterase‐5 inhibitor, namely tadalafil was administered concomitantly in an APP/PS1 mice model of AD with lower doses of the former. The gene discussed is HDAC9; the disease is Alzheimer disease.